Events
Dementias Platform UK Annual Conference, April 23, 2018
Meet the ROADMAP team at our exhibition stand during DPUK's Annual Conference entitled "Using the power of cohorts" on 23 April at the BMA House.
Information about the conference can be found here.

5th GA Meeting ROADMAP project, April 25-26, 2018
The 5th ROADMAP General Assembly Meeting is organised for ROADMAP partners from 25-26 April at Hotel Constanza in Barcelona.



Are you interested to learn more about ROADMAP and its activities?
Contact us at info@roadmap-alzheimer.org
International symposium on the use of real-world evidence in drug regulation and Health Technology Assessment, May 9, 2018
RWE for Regulation and HTA of Pharmaceuticals: current use and where do we go next?

The Utrecht Institute for Pharmaceutical Sciences will be holding an international symposium on the use of real-world evidence (RWE) in drug regulation and Health Technology Assessment (HTA) in Utrecht (the Netherlands) on 8 May. ROADMAP Expert Advisory Group member Amr Makady will highlight ROADMAP as an example of ongoing projects/ future trends for RWE use in regulation and HTA.
Background, aim and time planning are available here.
The symposium is limited to 70 participants, registration via: https://goo.gl/Uc9tTC

ISPOR 23rd Annual International Meeting, May 21, 2018
Real-World Evidence, Digital Health, and the New Landscape for Health Decision Making

Poster presentation: "Predictive modelling for secondary prevention of Alzheimer's disease: Ethical concerns and social implications based on targeted, narrative literature review". Z. Angehrn, et al., International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting, 19-23 May 2018, Baltimore MD (USA).
Find the programme here.

HTAi 2018 Meeting, June 1-5, 2018
Strengthening the Evidence-to-Action Connection



Oral presentation: “Regulatory and HTA considerations in Alzheimer’s disease”. J. Bouvy, HTAi 2018 Meeting, 1-5 June, Vancouver (Canada).
Find the programme here.
11th Research Day of the IDIAPJGol Institute, June 7, 2018
Roundtable discussion: “Real world data and dementia: contributions from the Information System for the development of primary care research (SIDIAP) and the Girona Dementia Register (ReDeGi)”. A. Ponjoan, 11th Research Day of the IDIAPJGol and the 10th Research Day of Catalan Health Institute (ICS), 7 June, Barcelona (Spain).

Find the programme here.

5th IME Summer Conference 2018, 19-20 June, 2018
Oral presentation: “Neuroethics in Dementia Prevention and Treatment: Ethical Issues Arising from the ROADMAP Project”. A. McKeown, 5th Institute of Medical Ethics Summer Conference, 19-20 June, Oxford (UK).

Find more information here.
32nd ESPMH Conference, August 22-25, 2018
Oral presentation: “Neuroethics in dementia prevention”. A. McKeown, 32nd European Conference on philosophy of medicine and health care, 24 August, Lisbon (Portugal).

Find the programme here.
Past presentations
  • Panel session: “The state of Alzheimer’s disease in Europe - innovation, value and challenges for HTA”. J. Bouvy, J. Georges, R. Handels, M. Knapp & C. Reed, Health Technology Assessment international (HTAi) Annual Meeting,17-21 June 2017, Rome (Italy).
  • Poster presentation: "Overcoming ethical issues in sharing real-world evidence in Alzheimer’s disease: The ROADMAP Project”. J. Krutzinna, Neuroethics Network 2017, 19-21 June 2017, Paris (France).
  • Poster presentation: “Real World Evidence for Alzheimer’s disease Outcomes”, Alzheimer's Association International Conference (AAIC), 16-20 July 2017, London (UK).
  • Oral presentation: “Actualités sur l’Aducanumab et étude ROADMAP”. Journées scientifiques de la fédération nationale des Centres Mémoire Ressources Recherche (FCMRR), 28-29 September 2017, Montpellier (France).
  • Symposium: “Engaging with patient organizations within IMI consortia to inform quality, relevance and value in Alzheimer’s research – insights from MOPEAD, EPAD and ROADMAP”. As part of Lilly symposium, Alzheimer Europe Conference, 2-4 October 2017, Berlin (Germany).
  • Poster presentation: “Challenges in Optimising Real World Evidence for Alzheimer’s Disease”. C. Reed, F. de Reydet de Vulpillieres, J. Gallacher, Clinical Trials on Alzheimer’s Disease (CTAD 2017), 1-4 November 2017, Boston, MA (USA).
  • Oral presentation: “Challenges in Optimizing Real World Evidence for Alzheimer’s Disease”. C. Reed, F. de Reydet de Vulpillieres, J. Gallacher, International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress, 4-8 November 2017, Glasgow (UK). http://www.sciencedirect.com/science/article/pii/S1098301517303716
  • Poster presentation: "A model for Alzheimer’s disease in the prevention setting". N. Hummel, et al., International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress 2017, 4-8 November 2017, Glasgow (UK).
  • Oral presentation: "The aims of the ROADMAP project". C. Reed, Alzheimer Association Academy, 5-6 December 2017, Brussels (Belgium).
  • Oral presentation: "The use of real-world data and evidence in regulatory and health technology assessments". M. Dekker, Alzheimer Association Academy, 5-6 December 2017, Brussels (Belgium).
  • Oral presentation: "Ethical issues raised by big data and real-world evidence projects". A. Turner, Alzheimer Association Academy, 5-6 December 2017, Brussels (Belgium).
  • Oral presentation: "Expert advisory involvement in ROADMAP". A. Santuccione Chadha, Closed meeting at Lausanne IV, 13 December 2017, Lausanne (Switzerland).
  • Poster presentation: “Real World Outcomes across the Alzheimer’s Disease spectrum for better care: Multi-modal data Access Platform”. O. Janssen, S. Vos, R. Handels, F. Verhey, P. J. Vissser,  Symposium: The Future of a Data-Driven Society, 25 January 2018, Maastricht (the Netherlands).
  • Oral presentation: “Real-world evidence in Alzheimer’s disease: the ROADMAP collaboration”. P. J. Visser, International Pharmaco-Economic Conference on Alzheimer's Disease (IPECAD), 15-16 February 2018, Paris (France).
  • Oral presentation: "Data sharing in biomedical research: practical questions". C. Diaz, XI Annual Conference of Technological Platforms in Biomedical Research, 5 March 2018, Barcelona (Spain).
  • Oral presentation: "Real world evidence for investigating AD outcomes: utilising platform resources". N. Vaci, IMI-EMIF Symposium ‘Liberating Evidence from European Health Data – the Achievements and Challenges of a Five-Year IMI Project’, 18 April 2018, Brussels (Belgium).